Lipidio Pharmaceuticals

Lipidio is focused on advancing a molecule to treat diseases associated with excess body fat including non-alcoholic steatohepatitis (NASH), Prader-Willi syndrome (PWS) and antipsychotic drug-induced weight gain (AIWG), which represent major unmet medical needs. Lipidio Pharma maintains its headquarters in San Diego, CA.

Scroll to Top